OTCM
PSYBF
Market cap0kUSD
May 13, Last price
0.00USD
Name
PsyBio Therapeutics Corp
Chart & Performance
P/E
—
P/S
—
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
0k
Net income
-5m
L-55.66%
CFO
-3m
L-50.54%
Profile
PsyBio Therapeutics Corp., a biotechnology company, focuses on the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States. The company is headquartered in Coconut Creek, Florida.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY |
|---|---|---|
| 2022‑12 | 2021‑12 | |
| Income | ||
Revenues | ||
Cost of revenue | 4,387 | |
Unusual Expense (Income) | ||
NOPBT | (4,387) | |
NOPBT Margin | ||
Operating Taxes | 49 | |
Tax Rate | ||
NOPAT | (4,437) | |
Net income | (4,886) -55.66% | |
Dividends | ||
Dividend yield | ||
Proceeds from repurchase of equity | 68 | |
BB yield | ||
| Debt | ||
Debt current | 135 | |
Long-term debt | 135 | |
Deferred revenue | ||
Other long-term liabilities | 50 | |
Net debt | 270 | |
| Cash flow | ||
Cash from operating activities | (3,437) | |
CAPEX | ||
Cash from investing activities | 3,524 | |
Cash from financing activities | (55) | |
FCF | (2,768) | |
| Balance | ||
Cash | 848 | |
Long term investments | ||
Excess cash | 848 | |
Stockholders' equity | (1,747) | |
Invested Capital | 342 | |
ROIC | ||
ROCE | 312.17% | |
| EV | ||
Common stock shares outstanding | 111,810 | |
Price | ||
Market cap | ||
EV | ||
EBITDA | (4,235) | |
EV/EBITDA | ||
Interest | 21 | |
Interest/NOPBT | ||